Human medicines European public assessment report (EPAR): Tevagrastim, filgrastim, Date of authorisation: 15/09/2008, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Ratiograstim, filgrastim, Date of authorisation: 15/09/2008, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Revatio, sildenafil, Date of authorisation: 28/10/2005, Revision: 53, Status: Authorised

Human medicines European public assessment report (EPAR): Iasibon, ibandronic acid, Date of authorisation: 21/01/2011, Revision: 13, Status: Authorised

List of centrally authorised products with safety-related changes to the Product Information

EU Individual Case Safety Report (ICSR) implementation guide business rules spreadsheets

Human medicines European public assessment report (EPAR): Zaltrap, aflibercept, Date of authorisation: 01/02/2013, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Ibandronic Acid Teva, ibandronic acid, Date of authorisation: 17/09/2010, Revision: 13, Status: Authorised

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 20 June 2024, 10:00 (CEST) to 20 June 2024, 13:30 (CEST)

Meeting summary - Medicine Shortages (SPOC) Working Party meeting on 20 June 2024